MetLife Investment Management’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.33M | Buy |
273,000
+10,360
| +4% | +$206K | 0.02% | 614 |
|
|
2026
Q1 | $5.05M | Buy |
262,640
+8,938
| +4% | +$176K | 0.03% | 614 |
|
|
2025
Q4 | $4.81M | Sell |
253,702
-11,275
| -4% | -$209K | 0.02% | 645 |
|
|
2025
Q3 | $4.94M | Sell |
264,977
-7,749
| -3% | -$145K | 0.02% | 639 |
|
|
2025
Q2 | $5.03M | Buy |
272,726
+1,104
| +0.4% | +$19.6K | 0.03% | 573 |
|
|
2025
Q1 | $4.75M | Sell |
271,622
-5,671
| -2% | -$95.6K | 0.03% | 637 |
|
|
2024
Q4 | $4.8M | Buy |
277,293
+19,744
| +8% | +$361K | 0.03% | 580 |
|
|
2024
Q3 | $4.79M | Sell |
257,549
-739
| -0.3% | -$12.5K | 0.03% | 548 |
|
|
2024
Q2 | $3.98M | Buy |
258,288
+17,894
| +7% | +$256K | 0.02% | 618 |
|
|
2024
Q1 | $3.55M | Sell |
240,394
-6,325
| -3% | -$87.6K | 0.02% | 682 |
|
|
2023
Q4 | $3.52M | Sell |
246,719
-2,046
| -0.8% | -$29.1K | 0.03% | 681 |
|
|
2023
Q3 | $3.47M | Sell |
248,765
-6,049
| -2% | -$77.4K | 0.03% | 631 |
|
|
2023
Q2 | $3M | Sell |
254,814
-1,897
| -0.7% | -$21.6K | 0.02% | 752 |
|
|
2023
Q1 | $2.95M | Sell |
256,711
-3,800
| -1% | -$47K | 0.02% | 749 |
|
|
2022
Q4 | $3.24M | Sell |
260,511
-5,992
| -2% | -$76.4K | 0.02% | 693 |
|
|
2022
Q3 | $3.5M | Buy |
266,503
+3,241
| +1% | +$47.9K | 0.03% | 599 |
|
|
2022
Q2 | $3.68M | Sell |
263,262
-345
| -0.1% | -$4.61K | 0.03% | 613 |
|
|
2022
Q1 | $3.93M | Buy |
263,607
+75,925
| +40% | +$1.04M | 0.03% | 673 |
|
|
2021
Q4 | $2.54M | Buy |
187,682
+4,735
| +3% | +$67K | 0.02% | 773 |
|
|
2021
Q3 | $2.69M | Sell |
182,947
-1,810
| -1% | -$30.6K | 0.02% | 706 |
|
|
2021
Q2 | $3.36M | Buy |
184,757
+3,865
| +2% | +$68.8K | 0.03% | 599 |
|
|
2021
Q1 | $3.14M | Sell |
180,892
-17,934
| -9% | -$315K | 0.03% | 649 |
|
|
2020
Q4 | $3.45M | Sell |
198,826
-4,458
| -2% | -$71.1K | 0.03% | 552 |
|
|
2020
Q3 | $2.8M | Sell |
203,284
-9,990
| -5% | -$147K | 0.03% | 571 |
|
|
2020
Q2 | $3.08M | Buy |
213,274
+9,437
| +5% | +$124K | 0.04% | 522 |
|
|
2020
Q1 | $2.23M | Buy |
203,837
+10,526
| +5% | +$194K | 0.03% | 566 |
|
|
2019
Q4 | $4.13M | Buy |
193,311
+959
| +0.5% | +$21.5K | 0.04% | 451 |
|
|
2019
Q3 | $4.42M | Buy |
192,352
+6,304
| +3% | +$134K | 0.05% | 383 |
|
|
2019
Q2 | $3.66M | Sell |
186,048
-366,819
| -66% | -$7.15M | 0.04% | 507 |
|
|
2019
Q1 | $10.8M | Buy |
552,867
+368,568
| +200% | +$6.98M | 0.03% | 509 |
|
|
2018
Q4 | $3.04M | Sell |
184,299
-5,220
| -3% | -$105K | 0.04% | 540 |
|
|
2018
Q3 | $4.38M | Sell |
189,519
-3,144
| -2% | -$71.2K | 0.04% | 425 |
|
|
2018
Q2 | $4.19M | Buy |
192,663
+824
| +0.4% | +$16.1K | 0.05% | 392 |
|
|
2018
Q1 | $3.39M | Sell |
191,839
-1,543
| -0.8% | -$27.2K | 0.04% | 533 |
|
|
2017
Q4 | $3.63M | Buy |
+193,382
| New | +$3.85M | 0.04% | 522 |
|
Other funds holding SBRA
CIM
MetLife Investment Management's SBRA Position: Q2 2026 in Review
MetLife Investment Management increased its Sabra Healthcare REIT (SBRA) stake by 3.9% in Q2 2026, buying an estimated $206K and bringing the position to 273,000 shares worth $5.33M. The position accounts for 0.02% of the portfolio, ranked #614.
MetLife Investment Management first reported a position in SBRA in Q4 2017 and has held it in 35 quarters since. The position peaked at $10.8M in Q1 2019. 464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.
- MetLife Investment Management held 273,000 shares of Sabra Healthcare REIT worth $5.33M as of Q2 2026.
- MetLife Investment Management bought 10,360 Sabra Healthcare REIT shares in Q2 2026, an estimated $206K.
- Sabra Healthcare REIT made up 0.02% of MetLife Investment Management's portfolio in Q2 2026, its #614 holding.
- MetLife Investment Management first reported a position in Sabra Healthcare REIT in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's Sabra Healthcare REIT position peaked at $10.8M in Q1 2019.
- 464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.